53923-77-6

Upstream product

• 19735-89-8 3-methyl-1-phenylpyrazolin-5(4H)-one 
• 77287-34-4 formamide 
• 20719-13-5 3-methyl-1-phenyl-4-formylpyrazol-5-one 
• 15900-11-5 (5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-(3-methyl-5-oxo-1-phenyl-1,5-dihydro-pyrazol-4-ylidene)-methane 
• 290-87-9 1,3,5-Triazine 
• 89-25-8 edaravone 
• 290-38-0 1,2,4-triazine 

Downstream Products

• 4173-73-3 1-phenyl-3-methyl-4-phenylaminomethylene-5-pyrazolone 

Relevant academic research and scientific papers

Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones

A method for treating neoplasia involving the administration of certain pyrazolinone derivatives.

4-(ARYLAMINOMETHYLENE)-2,4-DIHYDRO-3-PYRAZOLONES

5-Pyrazolinone derivatives of the general formula I: in which the R1-R3 variables are as defined herein and the physiologically acceptable salts thereof; processes for the preparation of these compounds, and in particular their use as selective inhibitors of cGMP-specific phosphodiesterase (cGMP PDE), thus as pharmaceutically active compounds